ID A0A2K6BU50_MACNE Unreviewed; 570 AA.
AC A0A2K6BU50;
DT 28-MAR-2018, integrated into UniProtKB/TrEMBL.
DT 28-MAR-2018, sequence version 1.
DT 27-MAR-2024, entry version 29.
DE SubName: Full=TRAF3 interacting protein 2 {ECO:0000313|Ensembl:ENSMNEP00000014940.1};
GN Name=TRAF3IP2 {ECO:0000313|Ensembl:ENSMNEP00000014940.1};
OS Macaca nemestrina (Pig-tailed macaque).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC Cercopithecidae; Cercopithecinae; Macaca.
OX NCBI_TaxID=9545 {ECO:0000313|Ensembl:ENSMNEP00000014940.1, ECO:0000313|Proteomes:UP000233120};
RN [1] {ECO:0000313|Ensembl:ENSMNEP00000014940.1}
RP IDENTIFICATION.
RG Ensembl;
RL Submitted (SEP-2023) to UniProtKB.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; A0A2K6BU50; -.
DR STRING; 9545.ENSMNEP00000014940; -.
DR Ensembl; ENSMNET00000039147.1; ENSMNEP00000014940.1; ENSMNEG00000031594.1.
DR GeneTree; ENSGT00940000161944; -.
DR OMA; QRYPVCA; -.
DR Proteomes; UP000233120; Unplaced.
DR Bgee; ENSMNEG00000031594; Expressed in pituitary gland and 12 other cell types or tissues.
DR GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR GO; GO:0005102; F:signaling receptor binding; IEA:Ensembl.
DR GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR GO; GO:0002344; P:B cell affinity maturation; IEA:Ensembl.
DR GO; GO:0001783; P:B cell apoptotic process; IEA:Ensembl.
DR GO; GO:0001782; P:B cell homeostasis; IEA:Ensembl.
DR GO; GO:0023035; P:CD40 signaling pathway; IEA:Ensembl.
DR GO; GO:1990959; P:eosinophil homeostasis; IEA:Ensembl.
DR GO; GO:0002447; P:eosinophil mediated immunity; IEA:Ensembl.
DR GO; GO:0001768; P:establishment of T cell polarity; IEA:Ensembl.
DR GO; GO:0007507; P:heart development; IEA:Ensembl.
DR GO; GO:0006959; P:humoral immune response; IEA:Ensembl.
DR GO; GO:0097400; P:interleukin-17-mediated signaling pathway; IEA:Ensembl.
DR GO; GO:0038173; P:interleukin-17A-mediated signaling pathway; IEA:Ensembl.
DR GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR GO; GO:0002269; P:leukocyte activation involved in inflammatory response; IEA:Ensembl.
DR GO; GO:0048535; P:lymph node development; IEA:Ensembl.
DR GO; GO:0048255; P:mRNA stabilization; IEA:Ensembl.
DR GO; GO:0070254; P:mucus secretion; IEA:Ensembl.
DR GO; GO:0042119; P:neutrophil activation; IEA:Ensembl.
DR GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; IEA:Ensembl.
DR GO; GO:0002230; P:positive regulation of defense response to virus by host; IEA:Ensembl.
DR GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR GO; GO:0070534; P:protein K63-linked ubiquitination; IEA:Ensembl.
DR GO; GO:0110012; P:protein localization to P-body; IEA:Ensembl.
DR GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR GO; GO:0043588; P:skin development; IEA:Ensembl.
DR GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR GO; GO:0072538; P:T-helper 17 type immune response; IEA:Ensembl.
DR GO; GO:0002334; P:transitional two stage B cell differentiation; IEA:Ensembl.
DR GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl.
DR GO; GO:0042092; P:type 2 immune response; IEA:Ensembl.
DR Gene3D; 3.40.50.11530; -; 1.
DR InterPro; IPR013568; SEFIR_dom.
DR PANTHER; PTHR34257; ADAPTER PROTEIN CIKS; 1.
DR PANTHER; PTHR34257:SF2; E3 UBIQUITIN LIGASE TRAF3IP2; 1.
DR Pfam; PF08357; SEFIR; 1.
DR PROSITE; PS51534; SEFIR; 1.
PE 4: Predicted;
KW Reference proteome {ECO:0000313|Proteomes:UP000233120}.
FT DOMAIN 405..546
FT /note="SEFIR"
FT /evidence="ECO:0000259|PROSITE:PS51534"
FT REGION 1..70
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 152..209
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 323..399
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 45..70
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 166..188
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 371..391
FT /note="Pro residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 570 AA; 64216 MW; 2A13149DC86ECBF5 CRC64;
MAPQLEEMNR SIPVEVDESE PYPSQLLKPI PEYSLEEESE PPAPNTRNMA PNSLSVPTTP
HNSSRDFSQA HATLKLANHQ RPVSQQVTCL RTQVLEDSED SFCRRHPGPG KAFPSGCSAV
SEPESESVVG VLPAEHPFSF MEKRNQWLGS QLSAASPDTG HDSDKSDQSL PNASADSSGS
SQAMVQRPQP HRNRAGLDLP TIDTGYDSQP QDVLGIRQLE RPLPLTSVCY PQDLPRPLRS
REFPQFEPQW YPACALPPNL SPRAPWNYHY HCPGSPDHQV PYGQDYPRAA YQQVIQPALP
GQPLPGASVR GLHPVQKVIL NYPSPWDQEE RPSQRDCSFL GLPRHQEQPH HQPPNRAGTP
GESLECPAEL RPQVPQPPSP AAVPRPPSNP PARGTLKTSN LPEELRKVFI TYSMDTAMEV
VKFVNFLLVN GFQTAIDIFE DRIRGIDIIK WMERYLRDKT VMIIVAISPK YKQDVEGAES
QLDEDEHGLH TKYIHRMMQI EFIKQGSMNF RFIPVLFPNA KKEHVPTWLQ NTHVYSWPKN
KKNILLRLLR EEEYVAPPRG PLPTLQVVPL
//